State licensure in telehealth
A provider licensed in Florida cannot treat a patient sitting in Ohio. That single rule shapes your provider network, your intake routing and which states you can profitably advertise in.
Key takeaways
- Telehealth is regulated by the patient's location, not the clinician's or the company's.
- A national brand needs credentialed coverage in every state it advertises in.
- Credentialing is a standing operation: licences expire, renew and lapse.
- Coverage gaps appear as unexplained decline rates in specific states.
- Some categories are further constrained by DEA scheduling on top of licensure.
The governing rule
Regulation follows the patient, not the clinic. Someone licensed only in Florida cannot see a patient sitting in Ohio, and it makes no difference where your company is registered or where that clinician happens to live.
This is the foundation of every operational decision downstream: which clinician sees which case, whether the encounter can be asynchronous, and in some categories whether the therapy is available at all.
Credentialing is an operation, not a task
Verification is not a one-time gate. Licences expire and renew on different cycles per state, DEA registrations have their own timelines, board certifications lapse, and malpractice coverage has to remain current.
A national brand therefore needs a standing process rather than an onboarding checklist.
- State licensure, verified per state before a provider sees a patient there.
- DEA registration where the category involves controlled substances.
- NPI and board certification.
- Malpractice and liability coverage, current.
- Primary-source verification and sanctions screening.
- Ongoing monitoring for expiry, lapse and disciplinary action.
How gaps show up in your data
Coverage problems rarely announce themselves. They appear as an unexplained decline rate or a long time-to-approval in a specific state, which is easy to misread as a demand or intake problem.
Reporting approval rate and time-to-decision broken out by state is what makes the real cause visible. A state with thin coverage is a state where your ad spend converts worse for reasons that have nothing to do with the ad.
Scheduling constrains further
Licensure is the floor. Some categories add constraints on top of it. Testosterone, as a DEA Schedule III substance, is available in a narrower set of states than the underlying provider network covers, and commonly carries a higher age floor.
That means your addressable map differs per category, and the intake has to know that rather than applying one rule to the whole catalog.
What to ask a platform
General assurances about 50-state coverage are not sufficient, because coverage varies by category.
- Which states have credentialed coverage for each category I intend to offer?
- How are cases assigned, and is it automatic on patient state?
- How is expiry and lapse monitored, and what happens to a case if a licence lapses mid-treatment?
- Can I see approval rate and time-to-decision broken out by state?
- For controlled-substance categories, which states are actually available?
Credentialed coverage across all 50 states and D.C.
PharmaBro maintains a credentialed provider network across all 50 states and D.C., with cases assigned automatically by patient state and licensure monitored on an ongoing basis rather than at onboarding.
Analytics break approval rate and decision time out by state, so a coverage gap surfaces as a number rather than as a mystery.
Conclusion
State licensure is the rule that quietly determines your addressable market, and it is enforced per category rather than per company.
Build the provider network for the states you intend to advertise in, assign cases automatically by patient location, and watch decline rates by state, because that is where coverage problems surface first.
Frequently asked questions
Which state's rules apply in telehealth?
Whichever state the patient is sitting in when the encounter happens. That same fact decides whether the first visit can be asynchronous and, for scheduled medications, whether you can serve them at all.
Do I need providers licensed in all 50 states?
Only in the states where you intend to accept patients. If you are buying national traffic, that effectively means all of them, which is why most operators use a platform that maintains the network rather than credentialing directly.
What happens if a provider's licence lapses?
Cases in that state can no longer be assigned to them, and if it happens mid-treatment the patient needs reassignment to another licensed provider. This is why ongoing monitoring matters more than onboarding verification.
References
Priya RaghunathanHead of Compliance Operations
Handles LegitScript, HIPAA posture, MSO structuring and state coverage. Writes the parts of this blog that operators wish someone had told them before they signed.

